Alembic Pharmaceuticals on Tuesday said it has received final approval from the US health regulator for its generic Silodosin capsules used in treatment of benign prostatic hyperplasia.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/37Kqmic
via IFTTT
0 comments:
Post a Comment